Search research articles
Contact Us
Filters
Showing results (31-40 of 137) with videos related to
Page
of 14
Sort By:
JTO Clinical and Research Reports
|
March 4, 2022
A Real-World Analysis of the Use of Systemic Therapy in Malignant Pleural Mesothelioma and the Differential Impacts on Overall Survival by Practice Pattern
Kathleen Kerrigan, Yeonjung Jo, Jonathan Chipman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 7, 2022
Real-World Outcomes of Patients With BRAF-Mutated Metastatic Colorectal Cancer Treated in the United States
Andrew Trunk, Matthew Braithwaite, Christopher Nevala-Plagemann, et al.
Statistical Methods in Medical Research
|
March 19, 2024
A matching-based machine learning approach to estimating optimal dynamic treatment regimes with time-to-event outcomes
Xuechen Wang, Hyejung Lee, Benjamin Haaland, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 4, 2022
Treatment Trends and Clinical Outcomes of Left-Sided RAS/RAF Wild-Type Metastatic Colorectal Cancer in the United States
Christopher Nevala-Plagemann, Siddharth Iyengar, Andrew D Trunk, et al.
Breast Cancer Research and Treatment
|
January 9, 2021
Endocrine therapy and radiotherapy use among older women with hormone receptor-positive, clinically node-negative breast cancer
Mei Wei, Xuechen Wang, Danielle N Zimmerman, et al.
Cancer Treatment and Research Communications
|
February 3, 2023
Real-world comparison of survival outcomes with cisplatin versus carboplatin in patients with limited-stage small-cell lung cancer
Shashank Sama, Kathleen Kerrigan, Jennifer A Sinnott, et al.
Oncology
|
April 3, 2015
Is the Proportion of Patients Diagnosed with Synchronous Stage IV Breast Cancer Who Survive More than Two Years Increasing over Time?
Shaheenah Dawood, Benjamin Haaland, Constance Albaracin, et al.
Pancreas
|
August 4, 2021
Survival Outcomes Based on Sequence of Therapy Using FOLFIRINOX and Nab-Paclitaxel + Gemcitabine in Metastatic Pancreatic Ductal Adenocarcinoma
Margaret Kelsey Baron, Xuechen Wang, Christopher Nevala-Plagemann, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 1, 2018
Cost-effectiveness of pembrolizumab as first-line therapy for advanced non-small cell lung cancer
Mina Georgieva, Joao P da Silveira Nogueira Lima, Pedro Aguiar, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 22, 2023
A Real-World Comparison of Regorafenib and Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer in the United States
Christopher Nevala-Plagemann, Shashank Sama, Jian Ying, et al.
Page
of 14
Search research articles
Search
Showing results (31-40 of 137) with videos related to
Sort By:
Page
of 14
JTO Clinical and Research Reports
|
March 4, 2022
A Real-World Analysis of the Use of Systemic Therapy in Malignant Pleural Mesothelioma and the Differential Impacts on Overall Survival by Practice Pattern
Kathleen Kerrigan, Yeonjung Jo, Jonathan Chipman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 7, 2022
Real-World Outcomes of Patients With BRAF-Mutated Metastatic Colorectal Cancer Treated in the United States
Andrew Trunk, Matthew Braithwaite, Christopher Nevala-Plagemann, et al.
Statistical Methods in Medical Research
|
March 19, 2024
A matching-based machine learning approach to estimating optimal dynamic treatment regimes with time-to-event outcomes
Xuechen Wang, Hyejung Lee, Benjamin Haaland, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 4, 2022
Treatment Trends and Clinical Outcomes of Left-Sided RAS/RAF Wild-Type Metastatic Colorectal Cancer in the United States
Christopher Nevala-Plagemann, Siddharth Iyengar, Andrew D Trunk, et al.
Breast Cancer Research and Treatment
|
January 9, 2021
Endocrine therapy and radiotherapy use among older women with hormone receptor-positive, clinically node-negative breast cancer
Mei Wei, Xuechen Wang, Danielle N Zimmerman, et al.
Cancer Treatment and Research Communications
|
February 3, 2023
Real-world comparison of survival outcomes with cisplatin versus carboplatin in patients with limited-stage small-cell lung cancer
Shashank Sama, Kathleen Kerrigan, Jennifer A Sinnott, et al.
Oncology
|
April 3, 2015
Is the Proportion of Patients Diagnosed with Synchronous Stage IV Breast Cancer Who Survive More than Two Years Increasing over Time?
Shaheenah Dawood, Benjamin Haaland, Constance Albaracin, et al.
Pancreas
|
August 4, 2021
Survival Outcomes Based on Sequence of Therapy Using FOLFIRINOX and Nab-Paclitaxel + Gemcitabine in Metastatic Pancreatic Ductal Adenocarcinoma
Margaret Kelsey Baron, Xuechen Wang, Christopher Nevala-Plagemann, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 1, 2018
Cost-effectiveness of pembrolizumab as first-line therapy for advanced non-small cell lung cancer
Mina Georgieva, Joao P da Silveira Nogueira Lima, Pedro Aguiar, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 22, 2023
A Real-World Comparison of Regorafenib and Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer in the United States
Christopher Nevala-Plagemann, Shashank Sama, Jian Ying, et al.
Page
of 14